When antibody titers help, and when they don’t
Bottom line
Antibody titer testing can help answer a narrow but important question in small animal practice: whether a dog or cat has measurable antibodies to certain core viral diseases. In a recent dvm360 explainer, Noga Shiller, DVM, and Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), outlined where titers are most useful and where they can mislead. The core takeaway aligns with major vaccination guidance: titers are most informative for core viral antigens such as canine distemper virus, canine parvovirus, canine adenovirus, and feline panleukopenia virus, but they are not a general substitute for vaccination, nor are they reliable for many non-core diseases. AAHA’s canine guidance says routine titer testing to decide whether to revaccinate at standard intervals is usually not advised, though it can be helpful in select cases, including prior vaccine reactions, suspected vaccine-related autoimmune disease, or vaccine-hesitant pet parents. (aaha.org)
Why it matters: For veterinary professionals, the article is a useful reminder that a positive titer for certain core viruses can support evidence of prior immune response, while a negative result is often easier to interpret operationally because it may prompt revaccination or closer risk assessment. The nuance matters in exam-room conversations: AVMA notes that higher titers do not always equal protection, and lower titers do not always mean protection is absent. That makes titers best used as one tool within individualized preventive care, rather than a shortcut around guideline-based vaccine planning. (ebusiness.avma.org)
What to watch: Expect titers to remain part of shared decision-making, especially as practices navigate vaccine hesitancy, adverse-event histories, travel requirements, and demand for more tailored preventive care. (veterinarypracticenews.com)
Key facts
- Topic
- Antibody titer testing in small animal practice
- Most useful for dogs
- Canine distemper virus, canine parvovirus, and canine adenovirus
- Most useful for cats
- Feline panleukopenia virus
- Not a substitute for
- Vaccination
- AAHA canine guidance
- Routine titer testing to decide revaccination at standard intervals is usually not advised
- When titers may help
- Prior vaccine reactions, suspected vaccine-related autoimmune disease, or vaccine-hesitant pet parents
- Key limitation
- Commercial assays vary, and not all measured antibodies are necessarily protective
- AVMA caution
- Higher titers do not always equal protection, and lower titers do not always mean protection is absent
- Rabies importation threshold
- 0.5 IU/mL for dog importation into the United States
Antibody titer testing is back in the spotlight as veterinarians and pet parents continue to look for more individualized vaccine decisions. A dvm360 article by Noga Shiller, DVM, and Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), revisits a familiar clinical question: when does a titer actually help, and when does it create more uncertainty than clarity? The answer, based on current guidance, is that titers can be clinically useful, but only in specific contexts and for specific pathogens. (aaha.org)
That debate has been building for years as companion animal vaccination moved away from the old default of annual core boosters toward longer revaccination intervals for many products. AAHA’s 2022 canine vaccination guidelines and the 2020 AAHA/AAFP feline vaccination guidelines both emphasize risk-based protocols rather than one-size-fits-all schedules. The WSAVA’s 2024 global guidelines likewise frame serology as a targeted tool, particularly for core viral diseases, not a blanket replacement for vaccination programs. (aaha.org)
The practical distinction is this: for dogs, titers are most meaningful for core viral antigens including distemper, parvovirus, and adenovirus; for cats, the strongest use case is panleukopenia. AAHA states that after maternal antibodies have waned, any detectable antibody indicates that an immune response has occurred, but it also cautions that commercial assays vary, and not all measured antibodies are necessarily protective. That limitation is one reason the guidelines do not assign universal “protective titer” cutoffs for routine practice. (aaha.org)
The same guidance also draws a line around what titers cannot do well. They are generally less useful for assessing immunity to many non-core diseases, and they do not fully capture cell-mediated immunity or mucosal protection. AVMA makes a similar point in client-facing educational material, noting that antibody titers do not replace vaccination programs and that both high and low results can be overinterpreted if taken out of context. (ebusiness.avma.org)
Industry and expert commentary suggests the clinical value of titers is often greatest in edge cases, not routine wellness care. AAHA says routine titer testing to determine the need for revaccination at recommended intervals is not usually advised, but may be reasonable in dogs with prior adverse vaccine responses, suspected vaccine-related autoimmune disease, or when pet parents are reluctant to vaccinate. Recent trade coverage has echoed that framing, describing titers as a useful communication and risk-management tool when practices need to confirm prior response to core vaccination or address hesitancy without abandoning prevention altogether. (aaha.org)
There are also settings where titers matter for reasons beyond routine wellness planning. Rabies serology, for example, can be required in importation scenarios, but that is a regulatory use case with specific thresholds and timing requirements, not a general proxy for routine rabies booster decisions in practice. CDC guidance for dog importation into the United States specifies a rabies antibody titer threshold of 0.5 IU/mL and outlines revaccination and redraw steps if a dog does not meet it. (cdc.gov)
Why it matters: For veterinary teams, the bigger issue is not whether titers are good or bad, but whether they are being used for the right question. In the right patient, a titer can support individualized care, reduce unnecessary revaccination concerns, and strengthen trust with vaccine-hesitant pet parents. In the wrong setting, it can create false reassurance or unnecessary confusion. The operational challenge is explaining that a positive titer for a core viral disease may be highly meaningful, while the absence of a titer result, or a result for a different pathogen, may not translate neatly into a yes-or-no immunity decision. (aaha.org)
What to watch: The next phase will likely center on how practices integrate point-of-care serology into preventive care workflows, especially as guideline-based vaccination, client demand for personalization, and regulatory use cases such as travel and importation continue to intersect. (doi.org)